# Sirolimus Eluting ORSIRO Stent Versus Biolimus-eluting NOBORI Stent

Study · id `cardio:ct-nct01879358` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01879358](<https://clinicaltrials.gov/study/NCT01879358>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01879358

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 2314 participants.

## Technical summary

Registry record NCT01879358. Randomized; no masking; primary purpose treatment. Start 2012-11 (registry gives no type); primary completion 2015-02 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 2314 participants (planned count; ClinicalTrials.gov record NCT01879358, source copy `cardio:ctgov-nct01879358-2020-09-18`, retrieved 2026-10-26)
- Start date: 2012-11 (registry gives no type) (ClinicalTrials.gov record NCT01879358, source copy `cardio:ctgov-nct01879358-2020-09-18`, retrieved 2026-10-26)
- Primary completion: 2015-02 (actual) (ClinicalTrials.gov record NCT01879358, source copy `cardio:ctgov-nct01879358-2020-09-18`, retrieved 2026-10-26)
- Completion: 2021-02-01 (anticipated) (ClinicalTrials.gov record NCT01879358, source copy `cardio:ctgov-nct01879358-2020-09-18`, retrieved 2026-10-26)
- Countries: Denmark (ClinicalTrials.gov record NCT01879358, source copy `cardio:ctgov-nct01879358-2020-09-18`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01879358-2020-09-18`, retrieved 2026-10-26)

## The registry's words

- Brief title: Sirolimus Eluting ORSIRO Stent Versus Biolimus-eluting NOBORI Stent
- Acronym: SORT OUT VII
- Condition: Coronary Artery Disease
- Condition: Ischemic Heart Disease
- Intervention (Device): Drug-eluting stent
- Lead sponsor: Odense University Hospital
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry intervention name matches this record once doses, forms and salt words are removed: Drug-eluting stent (`cardio:drug-eluting-stent`)
- Registry lists this organization as the lead sponsor: Odense University Hospital (`cardio:org-odense-university-hospital`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Randomized Comparison of a Biodegradable Polymer Ultrathin Strut Sirolimus-Eluting Stent With a Biodegradable Polymer Biolimus-Eluting Stent in Patients Treated With Percutaneous Coronary Intervention: The SORT OUT VII Trial (`cardio:pubmed-27412869`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Five-Year Clinical Outcome of the Biodegradable Polymer Ultrathin Strut Sirolimus-Eluting Stent Compared to the Biodegradable Polymer Biolimus-Eluting Stent in Patients Treated With Percutaneous Coronary Intervention: From the SORT OUT VII Trial (`cardio:pubmed-36649389`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Five-year outcomes of patients with diabetes mellitus treated with a sirolimus-eluting or a biolimus-eluting stents with biodegradable polymer. From the SORT OUT VII trial (`cardio:pubmed-39311502`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: ff2441a9d623ee4a71281831bb2bd53474157e25e316f347003cafbb68bfac81
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
